Standard

Prospektivnoe issledovanie gipolipidemicheskoĭ terapii u zhenshchin molodogo vozrasta, perenesshikh infarkt miokarda. / Svistov, A S; Galiullina, R Kh; Obrezan, A G.

In: Klinicheskaia meditsina, Vol. 81, No. 1, 2003, p. 52-5.

Research output: Contribution to journal › Article › peer-review

Harvard

Svistov, AS, Galiullina, RK & Obrezan, AG 2003, 'Prospektivnoe issledovanie gipolipidemicheskoĭ terapii u zhenshchin molodogo vozrasta, perenesshikh infarkt miokarda', Klinicheskaia meditsina, vol. 81, no. 1, pp. 52-5.

APA

Svistov, A. S., Galiullina, R. K., & Obrezan, A. G. (2003). Prospektivnoe issledovanie gipolipidemicheskoĭ terapii u zhenshchin molodogo vozrasta, perenesshikh infarkt miokarda. Klinicheskaia meditsina, 81(1), 52-5.

Vancouver

Svistov AS, Galiullina RK, Obrezan AG. Prospektivnoe issledovanie gipolipidemicheskoĭ terapii u zhenshchin molodogo vozrasta, perenesshikh infarkt miokarda. Klinicheskaia meditsina. 2003;81(1):52-5.

Author

Svistov, A S ; Galiullina, R Kh ; Obrezan, A G. / Prospektivnoe issledovanie gipolipidemicheskoĭ terapii u zhenshchin molodogo vozrasta, perenesshikh infarkt miokarda. In: Klinicheskaia meditsina. 2003 ; Vol. 81, No. 1. pp. 52-5.

BibTeX

@article{b19e89b6132a4e6ea75a0c244ca7a820,
title = "Prospektivnoe issledovanie gipolipidemicheskoĭ terapii u zhenshchin molodogo vozrasta, perenesshikh infarkt miokarda",
abstract = "A 3-year prospective trial has been performed of a course of ischemic heart disease (IHD) in postmyocardial infarction women (PIW) on antianginal treatment alone vs women on hypolipidemic drugs. IHD ran a less severe course in young PIW than in menopausal IHD. Aggravation of IHD occurred more frequently in women with previous MI and in hypertension. Comparison of the two groups of women demonstrated that hypolipidemic drugs improved a course of IHD in the women. In menopausal women taking hypolipidemic drugs IHD improvement occurred 6.2 times more frequently while aggravation 2.3 times less frequently than in women on standard antianginal treatment. Young women benefited from hypolipidemic therapy 1.6 times more frequently.",
keywords = "Adult, Age Factors, Aged, Female, Humans, Hypolipidemic Agents/therapeutic use, Menopause/physiology, Menstruation/physiology, Middle Aged, Myocardial Infarction/drug therapy, Prognosis, Prospective Studies, Treatment Outcome",
author = "Svistov, {A S} and Galiullina, {R Kh} and Obrezan, {A G}",
year = "2003",
language = "русский",
volume = "81",
pages = "52--5",
journal = "КЛИНИЧЕСКАЯ МЕДИЦИНА",
issn = "0023-2149",
publisher = "Медицина",
number = "1",

}

RIS

TY - JOUR

T1 - Prospektivnoe issledovanie gipolipidemicheskoĭ terapii u zhenshchin molodogo vozrasta, perenesshikh infarkt miokarda

AU - Svistov, A S

AU - Galiullina, R Kh

AU - Obrezan, A G

PY - 2003

Y1 - 2003

N2 - A 3-year prospective trial has been performed of a course of ischemic heart disease (IHD) in postmyocardial infarction women (PIW) on antianginal treatment alone vs women on hypolipidemic drugs. IHD ran a less severe course in young PIW than in menopausal IHD. Aggravation of IHD occurred more frequently in women with previous MI and in hypertension. Comparison of the two groups of women demonstrated that hypolipidemic drugs improved a course of IHD in the women. In menopausal women taking hypolipidemic drugs IHD improvement occurred 6.2 times more frequently while aggravation 2.3 times less frequently than in women on standard antianginal treatment. Young women benefited from hypolipidemic therapy 1.6 times more frequently.

AB - A 3-year prospective trial has been performed of a course of ischemic heart disease (IHD) in postmyocardial infarction women (PIW) on antianginal treatment alone vs women on hypolipidemic drugs. IHD ran a less severe course in young PIW than in menopausal IHD. Aggravation of IHD occurred more frequently in women with previous MI and in hypertension. Comparison of the two groups of women demonstrated that hypolipidemic drugs improved a course of IHD in the women. In menopausal women taking hypolipidemic drugs IHD improvement occurred 6.2 times more frequently while aggravation 2.3 times less frequently than in women on standard antianginal treatment. Young women benefited from hypolipidemic therapy 1.6 times more frequently.

KW - Adult

KW - Age Factors

KW - Aged

KW - Female

KW - Humans

KW - Hypolipidemic Agents/therapeutic use

KW - Menopause/physiology

KW - Menstruation/physiology

KW - Middle Aged

KW - Myocardial Infarction/drug therapy

KW - Prognosis

KW - Prospective Studies

KW - Treatment Outcome

M3 - статья

C2 - 12650098

VL - 81

SP - 52

EP - 55

JO - КЛИНИЧЕСКАЯ МЕДИЦИНА

JF - КЛИНИЧЕСКАЯ МЕДИЦИНА

SN - 0023-2149

IS - 1

ER -

ID: 87920693